David M. Knott’s Stemline Therapeutics, Inc. STML Stock Holding History

David M. Knott’s Portfolio STML Stock Details STML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-89,864	Closed	-$435K	–	106
2020 Q1	$435K	Sell	89,864 -55,611	-38%	-$361K	0.27%	48
2019 Q4	$1.55M	Buy	145,475 +37,541	+35%	+$373K	0.63%	30
2019 Q3	$1.12M	Buy	107,934 +7,300	+7%	+$95.5K	0.47%	38
2019 Q2	$1.54M	Sell	100,634 -57,161	-36%	-$827K	0.65%	28
2019 Q1	$2.03M	Buy	157,795 +2,000	+1%	+$22.6K	0.81%	28
2018 Q4	$1.48M	Buy	155,795 +50,508	+48%	+$655K	0.7%	28
2018 Q3	$1.75M	Buy	105,287 +15,287	+17%	+$245K	0.57%	31
2018 Q2	$1.45M	Hold	90,000	–	–	0.54%	33
2018 Q1	$1.38M	Buy	90,000 +15,008	+20%	+$234K	0.57%	26
2017 Q4	$1.17M	Hold	74,992	–	–	0.47%	26
2017 Q3	$832K	Buy	74,992 +33,300	+80%	+$313K	0.36%	36
2017 Q2	$384K	Buy	41,692 +31,692	+317%	+$264K	0.16%	55
2017 Q1	$86K	Buy	+10,000	New	+$91.1K	0.04%	59

David M. Knott's STML Position: Q2 2020 in Review

David M. Knott sold out of Stemline Therapeutics, Inc. (STML) in Q2 2020, closing a stake of 89,864 shares — an estimated $435K sold.

David M. Knott first reported a position in STML in Q1 2017 and held it in 13 quarters. The position peaked at $2.03M in Q1 2019. 0 funds tracked by Wall St. Rank hold STML as of Q2 2020.

David M. Knott reported no remaining Stemline Therapeutics, Inc. position as of Q2 2020 after selling out during the quarter.
David M. Knott sold 89,864 Stemline Therapeutics, Inc. shares in Q2 2020, an estimated $435K.
David M. Knott first reported a position in Stemline Therapeutics, Inc. in Q1 2017 and held it in 13 quarters.
David M. Knott's Stemline Therapeutics, Inc. position peaked at $2.03M in Q1 2019.
0 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q2 2020.

Based on David M. Knott's 13F filing for Q2 2020, filed 12 Aug 2020.